Paper · 41468237
Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries.
Danpanichkul P and 16 others. Cancer, 2026. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Papers, record 41468237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41468237
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Neoplasms | Major topic |
| Humans | |
| Female | |
| Male | |
| Incidence | |
| Global Health | |
| Middle Aged | |
| Aged | |
| Adult | |
| Adolescent | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA210964 | NCI NIH HHS | United States | P50CA210964 | PubMed | NIH RePORTER |
| R01 CA256977 | NIH HHS | United States | R01CA256977 | PubMed | NIH RePORTER |
| K08 CA259534 | NIH HHS | United States | K08CA259534 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,963,802 | Evolution and function of genetic polymorphisms in the Helicobacter pylori type IV secretion pilus protein CagL in gastric carcinogenesis. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42963802 | PubMed |
| 42,837,495 | Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study. | Br J Surg | 2026 | https://conductscience.org/library/papers/42837495 | PubMed |
| 42,837,076 | The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035. | Updates Surg | 2026 | https://conductscience.org/library/papers/42837076 | PubMed |
| 42,816,832 | Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation. | Mol Med | 2026 | https://conductscience.org/library/papers/42816832 | PubMed |
| 42,812,730 | Patterns and Frequency of Opioid Use Among Individuals With a History of Gastrointestinal Malignancy: A Cross-Sectional Analysis of the 2019-2020 National Health Interview Survey (NHIS). | Cureus | 2026 | https://conductscience.org/library/papers/42812730 | PubMed |
| 42,797,493 | Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797493 | PubMed |
| 42,780,747 | Bispecific antibodies in gastrointestinal cancers: current applications and future perspectives. | Front Oncol | 2026 | https://conductscience.org/library/papers/42780747 | PubMed |
| 42,766,638 | Application of symptom network analysis among patients with gastric cancer: A scoping review. | PLoS One | 2026 | https://conductscience.org/library/papers/42766638 | PubMed |
| 42,649,986 | Biological and Targeted Therapies in the Multidisciplinary Management of Gastrointestinal Cancers. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649986 | PubMed |
| 42,649,928 | Colorectal Cancer Burden and Trends in South-West Oltenia, Romania: A 15-Year Real-World Study from a Regional Referral Cancer Center. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649928 | PubMed |
1 to 10 of 22
See all 22 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41468237
GET https://conductscience.org/api/papers/v1/41468237/cited_by?page=2